The Science of Testosterone Replacement Therapy: Comparing the Evidence for Gels, Injections, and Pellets
For men diagnosed with clinical hypogonadism, choosing a testosterone replacement method means navigating distinct biological trade-offs. A review of the clinical evidence reveals how gels, injections, and pellets differ in their absorption curves, side-effect risks, and daily convenience.
- Endocrine Society Guidelines
- Emphasizes achieving physiologic testosterone levels while strictly monitoring for cardiovascular and prostate risks.
- American Urological Association
- Focuses on practical symptom management, cost-effective delivery, and individualized patient care.
Perspectives this story doesn't cover
- Health insurance providers determining coverage tiers for different modalities
- Compounding pharmacists who prepare custom TRT formulations
Key terms
- Hypogonadism
- A clinical condition where the body does not produce enough testosterone, accompanied by specific physical or cognitive symptoms.
- Pharmacokinetics
- How the body absorbs, distributes, metabolizes, and excretes a drug over time.
- Erythrocytosis
- An abnormal increase in the number of red blood cells, which can thicken the blood and increase cardiovascular risk.
- Supraphysiologic
- Hormone levels that are higher than what the body would naturally produce.
- Subcutaneous
- Situated or applied under the skin.
Key points
- Testosterone replacement therapy (TRT) requires choosing between gels, injections, and pellets.
- Gels provide steady daily absorption but carry a risk of transferring the hormone to others through skin contact.
- Injections are cost-effective but create a 'peak-and-trough' effect that can cause mood fluctuations and increase red blood cell counts.
- Pellets offer consistent long-term release over several months but require a minor surgical procedure to implant.
- Clinical guidelines emphasize that no single method is universally best; the choice should be individualized.
For a man navigating a new diagnosis of clinical hypogonadism, the immediate question is rarely whether to treat it, but how. The decision between rubbing a gel on your shoulders every morning, visiting a clinic for periodic injections, or having pellets implanted under your skin dictates your daily routine for the foreseeable future. More importantly, it dictates how your body actually experiences the hormone.
Testosterone replacement therapy (TRT) is not a one-size-fits-all prescription. The goal of any TRT regimen is to restore serum testosterone to a normal physiologic range, alleviating symptoms like profound fatigue, muscle loss, depressive moods, and cognitive fog. Both the Endocrine Society and the American Urological Association emphasize that treatment should only begin after multiple morning blood tests confirm a deficiency, combined with clear clinical symptoms.[2][3]
However, the human body naturally produces testosterone in a diurnal rhythm—peaking in the early morning and gradually tapering off by the evening. Exogenous (outside) testosterone delivery systems attempt to mimic or override this natural biological rhythm, and they do so with varying degrees of success depending on their pharmacokinetic profiles.[7]
Transdermal gels are currently the most commonly prescribed starting point for TRT. Applied daily to the shoulders, upper arms, or abdomen, these alcohol-based gels are absorbed through the skin and provide a steady, continuous release of the hormone into the bloodstream over a 24-hour period.[4]
The primary biological advantage of gels is their ability to maintain highly stable serum testosterone levels, avoiding the dramatic hormonal highs and lows associated with other methods. However, the practical trade-off is the risk of transference. Patients must be meticulously careful not to let women or children touch the application site until it is thoroughly washed, as secondary exposure can cause unintended and harmful hormonal effects.[1][4]
Intramuscular injections, typically administered every one to two weeks, represent the oldest and most cost-effective form of TRT. Formulations like testosterone cypionate or enanthate are injected deep into the gluteal or thigh muscle, creating a depot from which the hormone is gradually released into the circulation.[4]
Intramuscular injections, typically administered every one to two weeks, represent the oldest and most cost-effective form of TRT.
The biological reality of injections is the "peak-and-trough" effect. Within days of the injection, serum testosterone levels surge to supraphysiologic highs—often well above the normal reference range—before steadily declining to subphysiologic lows just before the patient is due for their next dose.[7]
This pharmacokinetic rollercoaster can translate into noticeable mood, libido, and energy fluctuations for the patient. Furthermore, the extreme initial peaks uniquely correlate with a higher risk of erythrocytosis—an abnormal increase in red blood cell mass that can thicken the blood, potentially increasing cardiovascular strain and requiring therapeutic phlebotomy or dose adjustments.[1][6]
Subcutaneous pellets offer a "set it and forget it" alternative for men who want to avoid daily applications and frequent needle sticks. During a brief in-office procedure, a physician implants several small, crystalline testosterone pellets under the skin, usually in the upper buttocks or hip area.[5]
These pellets slowly dissolve over three to six months, providing a highly consistent, steady-state release of testosterone. This method closely mimics the body's natural baseline without the daily hassle of gels or the extreme pharmacokinetic peaks of intramuscular injections.[5]
The downside lies in the procedure itself. Implantation requires a minor surgical incision and local anesthesia, carrying a small risk of infection or pellet extrusion, where the pellet works its way back out of the skin. Additionally, if a patient experiences adverse side effects or requires a rapid dose adjustment, the pellets cannot be easily removed; the patient and physician must simply wait for them to dissolve.[5]
When comparing guidelines from the American Urological Association and the Endocrine Society, a clear consensus emerges: no single delivery method is universally superior. The choice must be highly individualized, factoring in a patient's tolerance for needles, daily compliance habits, and specific risk factors like baseline hematocrit levels.[8][9]
Ultimately, the success of testosterone replacement therapy depends less on the specific modality and more on consistent, rigorous monitoring. Regular blood work to track serum testosterone, prostate-specific antigen (PSA), and hematocrit ensures that whichever method you choose remains safe, effective, and properly calibrated over the long term.[2][3]
Frequently asked
Does testosterone replacement therapy cause prostate cancer?
Current clinical guidelines state there is no compelling evidence that TRT causes prostate cancer, though it can stimulate the growth of existing prostate cancer, requiring regular screening.
Can I switch from injections to gels if I don't like the side effects?
Yes, physicians frequently transition patients between delivery methods to find the optimal balance of symptom relief and lifestyle convenience.
How long does it take to feel the effects of TRT?
Improvements in energy and libido often begin within three to four weeks, while changes in muscle mass and bone density can take several months.
Why this matters
If you are experiencing symptoms of low testosterone, the delivery method you choose dictates not just your daily routine, but how your body physically experiences the hormone. Understanding the biological differences between steady-state absorption and peak-and-trough cycles allows you to make a choice that aligns with your lifestyle and minimizes side effects.
Sources
[1]Sexual MedicineComparison of the Effects of Testosterone Gels, Injections, and Pellets on Serum Hormones, Erythrocytosis, Lipids, and Prostate-Specific Antigen
Read on Sexual Medicine →
[2]The Journal of Clinical Endocrinology & MetabolismEndocrine Society GuidelinesTestosterone Therapy in Men With Hypogonadism: An Endocrine Society* Clinical Practice Guideline
Read on The Journal of Clinical Endocrinology & Metabolism →
[3]The Journal of UrologyAmerican Urological AssociationEvaluation and Management of Testosterone Deficiency: AUA Guideline
Read on The Journal of Urology →
[4]Translational Andrology and UrologyAmerican Urological AssociationPharmacology of testosterone replacement therapy preparations
Read on Translational Andrology and Urology →
[5]Current Sexual Health ReportsA Review of Testosterone Pellets in the Treatment of Hypogonadism
Read on Current Sexual Health Reports →
[6]Translational Andrology and UrologyAmerican Urological AssociationAdult-onset hypogonadism: evaluation and role of testosterone replacement therapy
Read on Translational Andrology and Urology →
[7]AndrologyPharmacokinetics of testosterone therapies in relation to diurnal variation of serum testosterone levels as men age
Read on Andrology →
[8]Translational Andrology and UrologyAmerican Urological AssociationComparison of American Urological Association and Endocrine Society guidelines on testosterone replacement
Read on Translational Andrology and Urology →
[9]Endocrine SocietyEndocrine Society GuidelinesStatement on Testosterone Replacement Therapy
Read on Endocrine Society →
[10]Factlen Editorial TeamSynthesis by Factlen editorial team
Read on Factlen Editorial Team →
Comments
More in Health
See all →Thyroid Physiology
The Architecture of Thyroid Homeostasis: The HPT Axis, Deiodinases, and Peripheral Hormone Control
9 sources
Cancer Screening
FDA Staff Report Finds No Major Safety Concerns With Galleri Multicancer Blood Test
7 sources
Metabolic Therapies
Roche's Dual GLP-1/GIP Agonist Enicepatide Achieves 15.5% Weight Loss in Phase 2 Diabetes Trial
5 sources
Dental Fluorosis
How Clinical Indices Quantify Dental Fluorosis and When Enamel Protection Becomes a Cosmetic Deficit
7 sources
Every angle. Every day.
Get Health stories with full source coverage and perspective breakdowns delivered to your inbox.




